Skip to main content
OpenTrials
Completed

NCT Number: NCT00623701

Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation

Efficacy and Safety from a high-dosed sublingual grass pollen preparation

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Allergy Conjunctival Diseases Conjunctivitis Eye Diseases Hypersensitivity Immune System Diseases Infections Nose Diseases Otorhinolaryngologic Diseases Respiratory Tract Diseases Respiratory Tract Infections Rhinitis

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Prof. Kristian Reich, MD

Hamburg, 20354, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Allergic rhinoconjunctivitis attributable to grass pollen
  • Positive SPT
  • Positive EAST
  • Positive provocation Test

Exclusion criteria

  • Serious chronic disease
  • other perennial allergies

Treatment and study plan

Allerslit forte

Biological

sublingual placebo preparation, daily

Primary outcomes

  1. Symptom and Medication Score

    Time frame: Grass pollen season 2009

Sponsors and collaborators

Lead sponsor

Allergopharma GmbH & Co. KG

Industry

Registry information

Official study title

A Multicentre, Multinational, Placebo-controlled, Double-blind, Randomized Study to Evaluate Efficacy and Safety of a Perennial, Sublingual, Specific Immunotherapy in Patients With Rhinoconjunctivitis With/Without Controlled Asthma Caused by Grass Pollen

Acronym: ALLEGRA6

Important dates

Study start
2008
Primary completion
2011
Study completion
2012
First posted
Feb 26, 2008
Registry last updated
Nov 8, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.